BOSTON, MA, May 22, 2026 (GLOBE NEWSWIRE) — Netcapital Inc. (Nasdaq: NCPL) (“Netcapital” or the “Company”), a capital markets technology company leveraging regulatory infrastructure and proprietary market data to deliver AI-powered solutions, has scheduled a business update conference call for Thursday, May 28, 2026, at 4:30 p.m. ET. Newly appointed Chief Executive Officer Todd Violette will lead the discussion and provide investors with an overview of Netcapital’s strategic direction, including the Company’s ongoing business transformation, near-term priorities, and plans to leverage its regulatory infrastructure, proprietary market data, and AI-powered solutions to support growth-stage companies and expand its private capital markets platform. Conference Call Information The Company will host an investor...

VANCOUVER, British Columbia, May 22, 2026 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today that it has entered into a Technology Evaluation and License Option Agreement (the “Agreement”) with one of the world’s largest multinational food companies (the “Partner”). Under the terms of the Agreement, the Partner will conduct a commercial-scale evaluation of EnWave’s proprietary Radiant Energy Vacuum (“REV™”) dehydration technology for potential application across multiple food categories within the Partner’s extensive global product portfolio. Subject to successful completion of the evaluation program, the Agreement provides the Partner with the option to negotiate one or more commercial royalty-bearing licenses for the use of REV™ technology. The Partner...

In animal studies, human dermal fibroblast spheroids reduce disease severity, prevent relapse, and suppress key inflammatory pathways associated with chronic psoriatic disease HOUSTON, May 22, 2026 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials,  today announced preclinical data from its CYPS317 program for psoriasis presented at the Society for Investigative Dermatology 2026 Annual Meeting, held May 13-15, 2026, in Chicago, Illinois. A link to the poster can be found here. Psoriasis is a chronic inflammatory skin disease driven by dysregulated innate and adaptive immunity, with the IL-23/Th17...

HOUSTON, May 22, 2026 (GLOBE NEWSWIRE) — KOIL Energy Solutions, Inc. (OTCQB: KLNG), a specialist in deepwater energy production and distribution equipment and services, today announced the closing of a new asset-based lending facility. KOIL entered a $5 million asset-based revolving line of credit with nFusion Capital Finance, LLC, (“nFusion”), an Austin, Texas-based private working capital finance company. The facility, which will be drawn on an as-needed basis, will support working capital and accelerate KOIL’s strategy to expand its fleet of rental equipment, and replace a prior receivables factoring arrangement with a commercial bank, which has been repaid in full and terminated. As a result of this new facility and the payoff of the prior factoring arrangement, KOIL currently has no outstanding financial debt other than lease...

Bellwright, Above The Snow, and Honeycomb: The World Beyond showcases the value of Snail Games’ work with Polish studio partners CULVER CITY, Calif., May 22, 2026 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, and its subsidiary Wandering Wizard, today highlighted the progress made through its existing partnerships with three Polish development teams. Through collaborations with Above The Desk, creators of Above the Snow; Donkey Crew, the team behind Bellwright; and Frozen Way Games, who are currently developing Honeycomb: The World Beyond, Snail Games continues to expand its content pipeline, deepen its international development network, and demonstrate the value of working with high-potential studios in...

Recent Ebola and Hantavirus Outbreaks Underscore Increasing Institutional Demand for Advanced Disinfection Solutions Across Hospitals, Hotels, Cruise Ships, Transportation Hubs, and Public Facilities FREDERICK, Md., May 22, 2026 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today highlighted the growing importance of advanced environmental disinfection solutions as global health officials raise alarms over the rapidly escalating Ebola outbreak in Central Africa. The World Health Organization (“WHO”) has stated they are “deeply concerned about the scale and speed of the epidemic” as the outbreak continues to expand across multiple regions. The outbreak, now classified as a Public Health Emergency of International Concern, reportedly...

BEIJING, May 22, 2026 (GLOBE NEWSWIRE) — Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets for use in the broader digital content industry, today announced a platform development milestone for Gausspeed, its generative AI platform for film production, video generation, and digital content creation workflows. Leveraging NVIDIA Omniverse and Universal Scene Description (OpenUSD) -based architecture, Gausspeed is now connected to the Company’s large-scale, high-precision 3D digital asset library, which the Company believes represents an important step toward building a more scalable, asset-driven AI production infrastructure for professional digital content creation. Building on the...

Company to Draw on Substantial Experience with COVID Testing to Again Support Public Health Agencies if Needed  GAITHERSBURG, Md., May 22, 2026 (GLOBE NEWSWIRE) — 20/20 Biolabs, Inc. (Nasdaq: AIDX) (“20/20 Biolabs” or the “Company”), an early market entrant in AI powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, announced that it is developing contingency plans to establish Ebola and Hantavirus testing in its CAP-accredited CLIA laboratory if called upon to support or augment testing by public health laboratories. Early in the COVID-19 pandemic, 20/20 Biolabs was among the first companies in the U.S. to import, validate, and distribute rapid antibody tests. The Company provided large scale PCR lab testing under contracts with the Montgomery County and Maryland Departments...